Supplemental Material and Methods from Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC

Yun Liu,Xinran Zhang,Baicai Yang,Hao Zhuang,Hua Guo,Wen Wei,Yuan Li,Ruibing Chen,Yongmei Li,Ning Zhang

DOI: https://doi.org/10.1158/0008-5472.22418661.v1

2023-01-01

Abstract:This file contains all detailed Supplemental Material and Methods from this research.

What problem does this paper attempt to address?

Supplemental Tables from Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC

Yun Liu,Xinran Zhang,Baicai Yang,Hao Zhuang,Hua Guo,Wen Wei,Yuan Li,Ruibing Chen,Yongmei Li,Ning Zhang

DOI: https://doi.org/10.1158/0008-5472.22418658

2023-01-01

Abstract:This file contains all Supplemental tables that including clinicopathological information of HCC tissue samples and sequences of DNA primer, siRNAs, and shRNAs.
Supplemental Figures from Demethylation-Induced Overexpression of Shc3 Drives C-Raf–independent Activation of MEK/ERK in HCC

Yun Liu,Xinran Zhang,Baicai Yang,Hao Zhuang,Hua Guo,Wen Wei,Yuan Li,Ruibing Chen,Yongmei Li,Ning Zhang

DOI: https://doi.org/10.1158/0008-5472.22418664

2023-01-01

Abstract:This file contains all Supplemental figures and Legends for Supplemental figures. Figure S1: Increased Shc3 expression is associated with HCC metastasis. Figure S2: Shc3 interacts with MVP. Figure S3: Shc3/MVP complex activates the MEK and ERK pathway. Figure S4: Shc3 promotes HCC proliferation and invasion in vitro. Figure S5: Shc3 induces EMT by interacting with MVP. Figure S6: MVP rescues Shc3-induced proliferation and migration. Figure S7: DNA methylation affects Shc3 transcription. Figure S8: Shc3 promotes tumor growth and intrahepatic metastasis in vivo. Figure S9: Shc3 promotes tumor growth and intrahepatic metastasis through MVP in vivo.
Supplementary Methods and References from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer

Su Li,Yongli Luo,Yang Liu,Jing Yang,Chao Yao,Cheng Fang,Juanjuan Shan,Jun Chen,Fangfang Li,Limei Liu,Chungang Liu,Yong Xu,Lupin Jiang,Deyu Guo,Jesús Prieto,Matías A. Ávila,Junjie Shen,Cheng Qian

DOI: https://doi.org/10.1158/0008-5472.22412124.v1

2023-01-01

Abstract:Description of additional methods and procedures used in the study. Also includes Supplementary References.
Supplementary Methods, Figures 1-4 from Rho Kinase Phosphorylation Promotes Ezrin-Mediated Metastasis in Hepatocellular Carcinoma

Yong Chen,Dongmei Wang,Zhen Guo,Jun Zhao,Bing Wu,Hui Deng,Ti Zhou,Hongjun Xiang,Fei Gao,Xue Yu,Jian Liao,Tarsha Ward,Peng Xia,Chibuzo Emenari,Xia Ding,Winston Thompson,Kelong Ma,Jingde Zhu,Felix Aikhionbare,Kefen Dou,Shi-Yuan Cheng,Xuebiao Yao

DOI: https://doi.org/10.1158/0008-5472.22387211

2023-01-01

Abstract:Supplementary Methods, Figures 1-4 from Rho Kinase Phosphorylation Promotes Ezrin-Mediated Metastasis in Hepatocellular Carcinoma
Supplementary Methods from MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Mengyu Xie,Hong Zheng,Ranjna Madan-Lala,Wenjie Dai,Nicholas T. Gimbrone,Zhihua Chen,Fumi Kinose,Sarah A. Blackstone,Keiran S.M. Smalley,W. Douglas Cress,Eric B. Haura,Uwe Rix,Amer A. Beg

DOI: https://doi.org/10.1158/0008-5472.22422753

2023-01-01

Abstract:Supplementary Methods for Xie et al, MEK inhibition modulates cytokine response to mediate therapeutic efficacy in lung cancer
Demethylation-induced overexpression of Shc 3 drives c-Raf-independent activation of MEK / ERK in HCC Short Title : Shc 3 / MVP / MEK / ERK promotes HCC progress

Yun Liu,Xinran Zhang,Baicai Yang,Hao Zhuang,Hua Guo,Wen Wei,Yuan Li,Ruibing Chen,Yongmei Li,Ning Zhang

2018-01-01

Abstract:Invasion and intrahepatic metastasis are major factors of poor prognosis in patients with hepatocellular carcinoma (HCC). In this study, we show that increased Src homolog and collagen homolog 3 (Shc3) expression in malignant HCC cell lines associate with HCC invasion and metastasis. Shc3 was significantly upregulated in tumors of 33 HCC patient samples as compared to adjacent normal tissues. Further analysis of 52 HCC patient samples showed that Shc3 expression correlated with microvascular invasion, cancer staging, and poor prognosis. Shc3 interacted with major vault protein (MVP), resulting in activation of MEK1/2 and ERK1/2 independently of Shc1 and c-Raf; this interaction consequently induced epithelialmesenchymal transition (EMT) and promoted HCC cell proliferation and metastasis. The observed increase in Shc3 levels was due to demethylation of its upstream promoter, which allowed c-Jun binding. In turn, Shc3 expression promoted c-Jun phosphorylation in a positive feedback loop. Analysis of metastasis using a tumor xenograft mouse model further confirmed the role of Shc3 in vivo. Taken together, our results indicate the importance of Shc3 in HCC progression and identify Shc3 as a novel biomarker and potential therapeutic target in HCC. Research. on January 13, 2018. © 2018 American Association for Cancer cancerres.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 12, 2018; DOI: 10.1158/0008-5472.CAN-17-2432
Data from Demethylation-Induced Overexpression of Shc3 Drives C-Raf–independent Activation of MEK/ERK in HCC

Yun Liu,Xinran Zhang,Baicai Yang,Hao Zhuang,Hua Guo,Wen Wei,Yuan Li,Ruibing Chen,Yongmei Li,Ning Zhang

DOI: https://doi.org/10.1158/0008-5472.can-17-2432

IF: 11.2

2018-01-01

Cancer Research

Abstract:AbstractInvasion and intrahepatic metastasis are major factors of poor prognosis in patients with hepatocellular carcinoma (HCC). In this study, we show that increased Src homolog and collagen homolog 3 (Shc3) expression in malignant HCC cell lines associate with HCC invasion and metastasis. Shc3 (N-Shc) was significantly upregulated in tumors of 33 HCC patient samples as compared with adjacent normal tissues. Further analysis of 52 HCC patient samples showed that Shc3 expression correlated with microvascular invasion, cancer staging, and poor prognosis. Shc3 interacted with major vault protein, resulting in activation of MEK1/2 and ERK1/2 independently of Shc1 and c-Raf; this interaction consequently induced epithelial–mesenchymal transition and promoted HCC cell proliferation and metastasis. The observed increase in Shc3 levels was due to demethylation of its upstream promoter, which allowed c-Jun binding. In turn, Shc3 expression promoted c-Jun phosphorylation in a positive feedback loop. Analysis of metastasis using a tumor xenograft mouse model further confirmed the role of Shc3 in vivo. Taken together, our results indicate the importance of Shc3 in HCC progression and identify Shc3 as a novel biomarker and potential therapeutic target in HCC.Significance: Ectopic expression of Shc3 forms a complex with MVP/MEK/ERK to potentiate ERK activation and plays an important role in sorafinib resistance in HCC. Cancer Res; 78(9); 2219–32. ©2018 AACR.
Supplemental Materials and Methods from KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis

Peng Yuan,Xiao-Hong He,Ye-Fei Rong,Jing Cao,Yong Li,Yun-Ping Hu,Yingbin Liu,Dangsheng Li,Wenhui Lou,Mo-Fang Liu

DOI: https://doi.org/10.1158/0008-5472.22413540.v1

2023-01-01

Abstract:This file contains Materials and Methods that are involved in the figures of the main text and supplementary information. These materials and methods include information of plasmid constructs, cell transfection and viral transduction, RNA preparation and qRT-PCR, luciferase reporter assay, ChIP assay, therapeutic experiments in mice, and immunohistochemistry and in situ hybridization.
Supplementary Materials and Methods from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

PengXu Qian,Arindam Banerjee,Zheng-Sheng Wu,Xiao Zhang,Hong Wang,Vijay Pandey,Wei-Jie Zhang,Xue-Fei Lv,Sheng Tan,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22395995

2023-01-01

Abstract:PDF file - 190K, Includes patient and specimen data, reagent information, miRNA and siRNA transfection, and statistical analysis. Also includes supplementary references
Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395239.v1

2023-01-01

Abstract:Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
Supplementary Materials and Methods from DNMT1–MicroRNA126 Epigenetic Circuit Contributes to Esophageal Squamous Cell Carcinoma Growth via ADAM9–EGFR–AKT Signaling

Ronghua Liu,Jie Gu,Pei Jiang,Yijie Zheng,Xiaoming Liu,Xuechao Jiang,Enyu Huang,Shudao Xiong,Fengkai Xu,Guangwei Liu,Di Ge,Yiwei Chu

DOI: https://doi.org/10.1158/1078-0432.22460706.v1

2023-01-01

Abstract:This file contained the supplementary materials and methods including RNA extraction and quantitative real-time PCR, miRNA overexpression and RNA interference (RNAi), Cell proliferation and migration assays, Immunohistochemistry (IHC) and Western blotting, EGFR inhibitor (AG1478) and 5-aza-2'-deoxycytidine (5-aza-dC) treatments, ISH scoring, DNA methylation analysis, Target prediction, 3'-UTR vector preparation, and luciferase reporter assay, Tumor xenograft in nude mice, mRNA sequencing. As well as, legends of the six supplementary figures were included in this file.
Supplementary materials and methods from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Jialei Weng,Zheng Wang,Zhiqiu Hu,Wenxin Xu,Jia-Lei Sun,Fu Wang,Qiang Zhou,Shaoqing Liu,Min Xu,Minghao Xu,Dongmei Gao,Ying-Hao Shen,Yong Yi,Yi Shi,Qiongzhu Dong,Chenhao Zhou,Ning Ren

DOI: https://doi.org/10.1158/0008-5472.25964576.v1

2024-01-01

Abstract:Supplementary materials and methods
Supplementary Materials and Methods from M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma

Xinyao Qiu,Shuai Yang,Shan Wang,Jianmin Wu,Bo Zheng,Kaiting Wang,Siyun Shen,Seogsong Jeong,Zhixuan Li,Yanjing Zhu,Tong Wu,Xuan Wu,Rui Wu,Weiwei Liu,Hong-Yang Wang,Lei Chen

DOI: https://doi.org/10.1158/0008-5472.22429342

2023-01-01

Abstract:Supplementary Materials and Methods
Supplementary Materials and Methods from pik3ca Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer

Jian‐Xin Xu,Yan Wang,Youliang Wang,Tao Liu,Nai‐Ben Ming,Man-Sheng Li,Lin Li,Fei-Jiao Ge,Chun Gong,Jun-Yan Gu,Ru Jia,He-Fei Wang,Yuling Chen,Rongrui Liu,Chuanhua Zhao,Zhao-Li Tan,Jian Yang,Zhu Yu,Shuji Ogino,Zhenyun Qian

DOI: https://doi.org/10.1158/1078-0432.22463444.v1

2023-01-01

Abstract:Supplementary materials, methods and results
Supplementary Materials and Methods from Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma

Ké Li,Baiyong Shen,Xi Cheng,Ding Ma,Xiaoqian Jing,Xinyu Liu,Wenyan Yang,Chenghong Peng,Weihua Qiu

DOI: https://doi.org/10.1158/0008-5472.22412282

2023-01-01

Abstract:Supplementary Materials and Methods includingï¼š1.Patients, Tissue Specimens, and Cell Culture;2.Nested RT-PCR and Quantitative Real-time PCR;3.Construction of Recombinant Plasmids of FGFR3IIIc, FGFR3Î"7-9, and FGFR3AT-I and Transient Transfection of Cell Lines;4.Lentivirus Packaging, Virus Transduction, Fluorescent Cell Selection, and Proliferation Evaluation and so on...
Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Yufei Wang,Man Zhao,Lina Zhao,Yu Geng,Guanghao Li,Lin Chen,Jingxuan Yu,Hongfeng Yuan,Huihui Zhang,Haolin Yun,Ying Yuan,Guowen Wang,Jinyan Feng,Liang Xu,Shuai Wang,Chunyu Hou,Guang Yang,Ningning Zhang,Wei Lu,Xiaodong Zhang

DOI: https://doi.org/10.1158/0008-5472.22433561.v1

2023-01-01

Abstract:Supplementary materials and methods, Supplementary figures, Supplementary figure legends, Supplementary tables
Supplementary Methods and Materials, Figure Legend from ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM

Xuesong Liu,Matthew Genet,Jenna E. Haines,Elie K. Mehanna,Shanshan Wu,Hung-I Harry Chen,Yidong Chen,Abrar A. Qureshi,Jiali Han,Xiang Chen,David E. Fisher,Pier Paolo Pandolfi,Yuan Zhang

DOI: https://doi.org/10.1158/1541-7786.22514197

2023-01-01

Abstract:Supplementary Methods and Materials, Figure Legend
Supplementary Materials and Methods from LINC00869 Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Xiaowen Shao,Yamei Dang,Tingting Zhang,Nan Bai,Jianing Huang,Mengya Guo,Li Sun,Minghe Li,Xiao Sun,Xinran Zhang,Feng Han,Ning Zhang,Hao Zhuang,Yongmei Li

DOI: https://doi.org/10.1158/1541-7786.25325123.v1

2024-01-01

Abstract:Supplementary Materials and Methods：Plasma membrane protein extraction, Cdc42 activation assay, etc
Supplementary Table 2 from BMP4 Administration Induces Differentiation of CD133+ Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Lixing Zhang,Hefen Sun,Fangyu Zhao,Peixiang Lu,Ge Chen,Hong Li,Helei Hou,Mingxia Yan,Taoyang Chen,Guoping Jiang,Haiyang Xie,Ying Cui,Xiaowu Huang,Jia Fan,Ming Yao,Jinjun Li

DOI: https://doi.org/10.1158/0008-5472.22395141

2023-01-01

Abstract:PDF file - 47K, Sequences of primers used in this study

Supplemental Material and Methods from Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC

Supplemental Tables from Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC

Supplemental Figures from Demethylation-Induced Overexpression of Shc3 Drives C-Raf–independent Activation of MEK/ERK in HCC

Supplementary Methods and References from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer

Supplementary Methods, Figures 1-4 from Rho Kinase Phosphorylation Promotes Ezrin-Mediated Metastasis in Hepatocellular Carcinoma

Supplementary Methods from MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Demethylation-induced overexpression of Shc 3 drives c-Raf-independent activation of MEK / ERK in HCC Short Title : Shc 3 / MVP / MEK / ERK promotes HCC progress

Data from Demethylation-Induced Overexpression of Shc3 Drives C-Raf–independent Activation of MEK/ERK in HCC

Supplemental Materials and Methods from KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis

Supplementary Materials and Methods from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Supplementary Materials and Methods from DNMT1–MicroRNA126 Epigenetic Circuit Contributes to Esophageal Squamous Cell Carcinoma Growth via ADAM9–EGFR–AKT Signaling

Supplementary materials and methods from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Supplementary Materials and Methods from M<sup>6</sup>A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma

Supplementary Materials and Methods from <i>pik3ca</i> Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer

Supplementary Materials and Methods from Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma

Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Supplementary Methods and Materials, Figure Legend from ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM

Supplementary Materials and Methods from LINC00869 Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Supplementary Table 2 from BMP4 Administration Induces Differentiation of CD133<sup>+</sup> Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Supplemental Material and Methods from Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC

Supplemental Tables from Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC

Supplemental Figures from Demethylation-Induced Overexpression of Shc3 Drives C-Raf–independent Activation of MEK/ERK in HCC

Supplementary Methods and References from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer

Supplementary Methods, Figures 1-4 from Rho Kinase Phosphorylation Promotes Ezrin-Mediated Metastasis in Hepatocellular Carcinoma

Supplementary Methods from MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Demethylation-induced overexpression of Shc 3 drives c-Raf-independent activation of MEK / ERK in HCC Short Title : Shc 3 / MVP / MEK / ERK promotes HCC progress

Data from Demethylation-Induced Overexpression of Shc3 Drives C-Raf–independent Activation of MEK/ERK in HCC

Supplemental Materials and Methods from KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis

Supplementary Materials and Methods from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Supplementary Materials and Methods from DNMT1–MicroRNA126 Epigenetic Circuit Contributes to Esophageal Squamous Cell Carcinoma Growth via ADAM9–EGFR–AKT Signaling

Supplementary materials and methods from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Supplementary Materials and Methods from M&lt;sup&gt;6&lt;/sup&gt;A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma

Supplementary Materials and Methods from &lt;i&gt;pik3ca&lt;/i&gt; Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer

Supplementary Materials and Methods from Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma

Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Supplementary Methods and Materials, Figure Legend from ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM

Supplementary Materials and Methods from LINC00869 Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Supplementary Table 2 from BMP4 Administration Induces Differentiation of CD133&lt;sup&gt;+&lt;/sup&gt; Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Supplementary Materials and Methods from M<sup>6</sup>A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma

Supplementary Materials and Methods from <i>pik3ca</i> Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer

Supplementary Table 2 from BMP4 Administration Induces Differentiation of CD133<sup>+</sup> Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma